1. Home
  2. BH vs IVA Comparison

BH vs IVA Comparison

Compare BH & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$321.11

Market Cap

971.1M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$3.84

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BH
IVA
Founded
1934
2011
Country
United States
France
Employees
2359
77
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.1M
883.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BH
IVA
Price
$321.11
$3.84
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$16.20
AVG Volume (30 Days)
65.0K
527.0K
Earning Date
05-04-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$751.20
P/E Ratio
$597.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$234.92
$2.94
52 Week High
$483.60
$7.98

Technical Indicators

Market Signals
Indicator
BH
IVA
Relative Strength Index (RSI) 69.03 32.92
Support Level $326.06 $3.77
Resistance Level $362.62 $4.67
Average True Range (ATR) 14.90 0.31
MACD 5.57 -0.09
Stochastic Oscillator 100.00 10.70

Price Performance

Historical Comparison
BH
IVA

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: